MRD / Regn No. : THBC\23-24\03054 Date : 23/06/2026
Patient Name : Shailaja Pansare Age & Gender : 41 Yrs. / Female
Contact No. : 9850189100 UHID :
Ht / Wt / BMI : 158 / 55.50 / 22.23 BP S / BP D : 130 / 87
Allergies : NONE Referred By :
   
Problem List : HYPOTHYROIDISM (05/Jan/2009) |
Subjective : HYPOTHYROIDISM SINCE 2021,HBA1C 7% ONLY ONCE,JT PAIN,MOTHER - IHD / ANGIOPLASTY,FATHER HAD SEVERE DM / CKD
Objective : 21-JUN-2026 REPORTS,HB-10.40/ HBA1C-7%,FBS-104,ALT-20/ AST-27,CR-0.75,URIC ACID-3,TC-134/ TG-102/ LDL-74.60/ HDL-39,T3-0.64/ T4-11.52/ TSH-0.690,VITD-25.40,VIT B12 558
Plan : CAN CONSIDER GLP1 ANALOG FOR CVD PROTECTION / CKD PREVENTION  
S# Generic (Trade) Name Route Dosage Usage Duration
1 DRISE 60,000 UNITS ORAL 1/WEEK ANYTIME OF DAY
3 MTHS
2 BIZFER XT ORAL 0-0-1 ALTERNATE DAY
3 MTHS
3 ONDERO MET 2.5+500 MG ORAL 0-0-1 AD
3 MTHS
4 ELTROXIN 75 MCG ORAL 1-0-0 30 MINS BBF / SKIP EVERY SUNDAY
3 MTHS
5 ROSUVAS F 5 MG ORAL 0-0-1 AD
3 MTHS
6 NUROKIND FAST ORAL 0-1-0 ONCE A WEEK
3 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 12/Jun/2026
Tests Suggested For Next Visit : HBA1C > 2 MTHS / AFTER 4 MTHS - FBS / PPBS / HBA1C / TSH / LIPID PROFILE
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: